Effect of Patients’ Risks and Preferences on Health Gains With Plasma Glucose Level Lowering in Type 2 Diabetes Mellitus | Zendy

Sandeep Vijan | Zendy; Jeremy B. Sussman | Zendy; John Yudkin | Zendy; Rodney A. Hayward | Zendy

Open Access

Effect of Patients’ Risks and Preferences on Health Gains With Plasma Glucose Level Lowering in Type 2 Diabetes Mellitus

Author(s) -

Sandeep Vijan,

Jeremy B. Sussman,

John Yudkin,

Rodney A. Hayward

Publication year - 2014

Publication title -

jama internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.14

H-Index - 342

eISSN - 2168-6114

pISSN - 2168-6106

DOI - 10.1001/jamainternmed.2014.2894

Subject(s) - medicine , glycemic , diabetes mellitus , type 2 diabetes mellitus , type 2 diabetes , randomized controlled trial , quality adjusted life year , observational study , insulin , cost effectiveness , endocrinology , risk analysis (engineering)

Type 2 diabetes mellitus is common, and treatment to correct blood glucose levels is standard. However, treatment burden starts years before treatment benefits accrue. Because guidelines often ignore treatment burden, many patients with diabetes may be overtreated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research